Companies
Employees11-50
Funding$41.4M
Valuation$60-90M
7 active roles
Healthcare AIAI ApplicationB2B SaaS$10M-$50M
About
Axiom Bio is a San Francisco-based biotechnology firm operating at the intersection of machine learning, biochemistry, and life sciences. The company develops AI-driven predictive models to provide frontier intelligence for human drug toxicity, enabling scientists to reduce unexpected toxicity and develop safer medicines with less animal testing.
Active Roles
7Key Investors
Crane Venture Partners